Taha, Taha Y. http://orcid.org/0000-0002-7344-7490
Chen, Irene P. http://orcid.org/0000-0002-5766-9253
Hayashi, Jennifer M. http://orcid.org/0000-0001-7153-9212
Tabata, Takako
Walcott, Keith http://orcid.org/0000-0003-2896-2431
Kimmerly, Gabriella R.
Syed, Abdullah M.
Ciling, Alison http://orcid.org/0000-0002-8393-6829
Suryawanshi, Rahul K.
Martin, Hannah S.
Bach, Bryan H. http://orcid.org/0000-0003-1420-6344
Tsou, Chia-Lin
Montano, Mauricio
Khalid, Mir M.
Sreekumar, Bharath K.
Renuka Kumar, G.
Wyman, Stacia http://orcid.org/0000-0002-8937-8397
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Ott, Melanie http://orcid.org/0000-0002-5697-1274
Funding for this research was provided by:
Roddenberry Foundation
P. and E. Taft the Pendleton Foundation Chan Zuckerberg Biohub – San Francisco
Article History
Received: 1 February 2023
Accepted: 31 March 2023
First Online: 21 April 2023
Competing interests
: The authors declare the following competing interests: T.Y.T., T.T., and M.O. are inventors on a patent application filed by the Gladstone Institutes that covers the use of pGLUE to generate SARS-CoV-2 infectious clones and replicons. All other authors declare no competing interests.